Rab GTPases drive ligand-independent NOTCH1 activation via altered endocytic trafficking in chronic lymphocytic leukemia. [PDF]
De Falco F +17 more
europepmc +1 more source
Association between serum biomarkers and clinical stage in treatment-naïve chronic lymphocytic leukemia. [PDF]
Khosravifarsani M +7 more
europepmc +1 more source
Treatment of Cold Agglutinin Syndrome Secondary to Chronic Lymphocytic Leukemia With Sutimlimab and Obinutuzumab-Venetoclax. [PDF]
Lap CJ, Broome CM.
europepmc +1 more source
Treatment, Monitoring, and Management of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: Evidence From a Multi-Country Needs Assessment. [PDF]
Lazure P +9 more
europepmc +1 more source
Estimated cardiac deaths associated with treating chronic lymphocytic leukemia with ibrutinib versus zanubrutinib in the United States. [PDF]
Brown JR +9 more
europepmc +1 more source
Papillary thyroid carcinoma in a patient with long-standing chronic lymphocytic leukemia: A case report. [PDF]
Ma J +5 more
europepmc +1 more source
CaMKK2 Expression Correlates with High-Risk CLL Biology, and Pharmacologic Inhibition Is Associated with Reduced Leukemic Cell Survival and Nurse-like Cell Support In Vitro. [PDF]
Jauhari S +7 more
europepmc +1 more source
Reduced colony-stimulating factor 1 receptor expression in myeloid cells has limited impact on chronic lymphocytic leukaemia progression. [PDF]
Rosen N +14 more
europepmc +1 more source
A Case of Pseudo-Richter Transformation Following Zanubrutinib Discontinuation in CLL. [PDF]
Laurenti L +14 more
europepmc +1 more source

